An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy

Lishuang Qi(Harbin Medical University), Zheng Guo(Harbin Medical University), Yang Li(Harbin Medical University), Wenyuan Zhao(Jiangxi University of Science and Technology), Gengen Shi(Harbin Medical University), Yunyan Gu(Harbin Medical University), Jiasheng Wang(Harbin Medical University), Tianhao Li(Tianjin First Center Hospital), Libin Chen(Central South University), Yuan Qin(Fujian Agriculture and Forestry University)
British Journal of Cancer
November 17, 2016
Cited by 50


Related Papers